India's Largest Database on New Projects
Ranbaxy Labs, Merck tie up to develop anti-infective drugs
May 13, 2008: Ranbaxy Laboratories has entered into a long-term drug discovery and development agreement with the US-based Pharma company Merck in the area of anti-infective medicines.
The agreement calls for joint research to develop clinically validated anti-bacterial and anti-fungal drug candidates. Ranbaxy will undertake early stages of the drug discovery, while the later-phase clinical trials and commercialisation of drug candidates will be Merck's responsibility.
Ranbaxy will have a dedicated team of scientists to look into the research tie-up. The agreement is applicable for an initial term of five years, with provisions for further extensions.
Source: Business Standard